The hypoparathyroidism drug pipeline is advancing with novel hormone replacement therapies and long-acting PTH analogs, driven by unmet needs and rising awareness of rare endocrine disorders. https://social.contadordeinscritos.xyz/blogs/13972/Hypoparathyroidism-Drug-Pipeline-Analysis-Trend-Analysis-and-Future-Outlook-2034